Zambia Healthy Choices Project for Emerging Adults Living With HIV
- Conditions
- Pre-Exposure Prophylaxis
- Interventions
- Behavioral: Mobile Healthy Choices (mHC)Behavioral: Motivational Text Messaging (MTM)Behavioral: Standard ART Counseling
- Registration Number
- NCT06415357
- Lead Sponsor
- University of Massachusetts, Worcester
- Brief Summary
This project will develop and implement a multi-component intervention using mobile health technology to improve HIV self-management and reduce substance use. Specifically, the investigators will adapt Healthy Choices (HC) to develop mobile HC (mHC) and develop Motivational text messaging (MTM) for Zambian emerging adults living with HIV.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Aged between 18 and 24 years
- Report visual analogue scale showing <80% medication adherence in the last month AND problematic/risky alcohol use in the last month
- Speak English, Nyanja, or Bemba
- Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
- currently enrolled in another HIV intervention study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Standard ART counseling, mHC, and MTM Motivational Text Messaging (MTM) Participants in this arm will receive standard ART counseling, followed by two mHealth interventions (mHC and MTM) to improve PrEP uptake and adherence. Standard ART counseling, mHC, and MTM Standard ART Counseling Participants in this arm will receive standard ART counseling, followed by two mHealth interventions (mHC and MTM) to improve PrEP uptake and adherence. Standard ART counseling, mHC, and MTM Mobile Healthy Choices (mHC) Participants in this arm will receive standard ART counseling, followed by two mHealth interventions (mHC and MTM) to improve PrEP uptake and adherence. Standard ART counseling and MTM Motivational Text Messaging (MTM) Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (MTM) to improve PrEP uptake and adherence. Standard ART counseling and mHC Standard ART Counseling Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (mHC) to improve PrEP uptake and adherence. Standard ART counseling and mHC Mobile Healthy Choices (mHC) Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (mHC) to improve PrEP uptake and adherence. Standard ART counseling and MTM Standard ART Counseling Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (MTM) to improve PrEP uptake and adherence. Standard ART counseling Standard ART Counseling Participants in this arm will receive standard ART counseling.
- Primary Outcome Measures
Name Time Method Intervention Acceptability: Client Satisfaction Questionnaire (CSQ-8) Month 6 CSQ-8 is an 8-item, 4-point Likert scale measuring the construct of global intervention satisfaction. The total possible composite score ranges from 8 to 32, with higher scores indicating greater acceptability.
Intervention Acceptability: Exit Interview Month 3 Participants will be invited to share their experiences with mHC and MTM, including feedback on acceptability, ease of use, suggestions for improvement, and impact on ART adherence and alcohol use reduction.
Intervention Acceptability: System Usability Score (SUS) Month 6 SUS is a 10-item, 5-point Likert scale for subjective assessment of usability. Each item ranges from 1 to 5. Depending on the item, the score is calculated by subtracting either one from the user response or the user response from 5. Then, the score for each item will be summed and multiplied by 2.5 for the total score. The overall SUS scores range from 0 to 100. A score of \> 50 indicates that the technology-based interventions are acceptable.
Intervention Feasibility: Number of Responses to MTM Baseline to Month 6 Intervention feasibility will be evaluated by the total number of responses to MTM.
ART Adherence: Visual Analog Scale Baseline, Month 3, and Month 6 ART adherence will be assessed through the Young Adult Adherence Interview via computer-assisted self-interview (CASI) survey, which contains a visual analog scale (VAS) ranging from 0 to 100. Higher percentages on the VAS indicate greater adherence to ART.
ART Adherence: Self-Reported Adherence Baseline, Month 3, and Month 6 ART adherence will be evaluated through self-reported adherence over the past four weeks via a CASI survey. Participants will rate their adherence on a scale ranging from 0 to 100%, with higher percentages indicating better adherence to ART.
ART Adherence: Dried Blood Spot (DBS) Testing Baseline, Month 3, and Month 6 ART adherence will be evaluated by examining the HIV viral load in DBS. Maintaining a viral load of less than 200 copies/ml will indicate adherence to ART.
Alcohol Use: The Timeline Followback (TLFB) Interview Baseline, Month 3, and Month 6 Alcohol use will be assessed using the TLFB interview. Using a calendar, participants will be asked to provide estimates of their daily drinking over the last 30 days, as well as the max number of drinks in a one-week period, the number of heavy drinking days, the number of standard drinks in 30 days, and binge drinking.
Intervention Feasibility: Participant Retention Baseline to Month 6 Intervention feasibility will be assessed based on participant retention at Month 6. The retention rate can range from 70 to 90%, with a retention rate of over 85% deemed the minimum criterion for feasibility.
Intervention Feasibility: Number of mHC Sessions Completed Baseline to Month 6 Intervention feasibility will be evaluated by the number of completed intervention sessions.
- Secondary Outcome Measures
Name Time Method Sexual Risk Baseline, Month 3, and Month 6 Sexual risk will be assessed using TLFB interview via CASI, capturing sexual behavior over the past 30 days, such as condom usage and the number of sexual partners.
Information: HIV Knowledge Baseline, Month 3, and Month 6 HIV transmission risk awareness will be evaluated through an 18-item HIV Knowledge Questionnaire. Total possible composite scores range from 0 to 18, with higher scores indicating a higher level of HIV knowledge.
Drug Use: Alcohol Use Disorder Identification Text (AUDIT-C) Baseline, Month 3, and Month 6 Alcohol use will be assessed by using AUDIT-C to identify individuals with hazardous drinking habits or alcohol use disorders. Each item scores from 0 to 4, with 0 indicating no alcohol consumption. The total score maxes out at 12, with higher scores suggesting greater risks of harm.
Behavioral Skills: Self-Efficacy Baseline, Month 3, and Month 6 Behavioral skills in HIV self-management will be assessed using a 5-item adapted version of the Self-Efficacy for Health Promotion and Risk Reduction Questionnaire. This 5-point Likert scale measures confidence levels (score range: 5-25), with higher scores indicating greater confidence in HIV self-management tasks.
Mental health: Brief Symptom Inventory (BSI-18) Baseline, Month 3, and Month 6 Mental health will be evaluated with BSI-18. This 18-item questionnaire utilizes a 5-point Likert scale to gauge psychological distress. Scores range up to 72, with higher scores indicating a higher level of psychological distress.
Information: ART Knowledge Baseline, Month 3, and Month 6 ART knowledge will be evaluated through a 21-item HIV Treatment Knowledge Questionnaire. Total possible composite scores range from 0 to 21, with higher scores indicating a higher level of ART knowledge.
Motivation: Decisional Balance for Problem Behavior Baseline, Month 3, and Month 6 Attitudes toward risk behaviors will be assessed using the 32-item Decisional Balance for Problem Behavior scale. This 5-point Likert scale evaluates the perceived pros and cons of engaging in risk behaviors
STI Diagnosis: Number of participants who are diagnosed with syphilis, gonorrhea, or chlamydia Baseline and Month 6 Syphilis testing will employ a treponemal test with rapid plasma reagin (RPR), while gonorrhea and chlamydia testing will utilize pooled urine, oropharyngeal, and rectal swabs.
Drug Use: Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Baseline, Month 3, and Month 6 Drug use will be assessed with ASSIST, which is a questionnaire to identify substance use health risks and disorders, with each item scored from 0 to 12. The total score ranges up to 24, with higher scores indicating greater risk based on current substance use patterns.
Social support: Social Provision Scale Baseline, Month 3, and Month 6 Social support will be evaluated using the Social Provision Scale. This 5-point Likert scale, 13-item survey assesses the availability of social support, such as emotional, information, and instrumental support, as well as companionship and social isolation. Scores range up to 65, with higher scores indicating more extensive availability of social support.
HIV stigma: Shortened Version of Berger's Stigma Scale Baseline, Month 3, and Month 6 HIV-related stigma will be evaluated using the 10-item Berger's Stigma Scale. This scale, based on a 4-point Likert scale, assesses the stigma perceived by people living with HIV. The score can range from 10 to 40, with a higher score indicating greater perceived stigma associated with HIV.
Motivation: Rollnick's Readiness Ruler Baseline, Month 3, and Month 6 Intentions to improve HIV self-management and alcohol consumption behaviors will be evaluated using the 5-item Rollnick's Readiness Ruler. Each item ranges from 0 to 10, with higher scores indicating a greater readiness for change.
Trial Locations
- Locations (1)
University of Zambia
🇿🇲Lusaka, Zambia